The Impact of Sodium on Prognosis in RCC and NSCLC Patients Receiving Second-line Nivolumab Treatment

Objective: This study aimed to explore whether serum sodium concentrations could serve as a prognostic marker in patients with metastatic renal cell carcinoma (mRCC) and metastatic non-small cell lung cancer (mNSCLC) who were treated with nivolumab in the second-line setting. Material and Methods:...

Celý popis

Podrobná bibliografie

Hlavní autoři:	İsmet SEVEN, Selin AKTÜRK ESEN, İrfan KARAHAN, Efnan ALGIN, Öznur BAL, Şebnem YAMAN, Doğan UNCU
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Turkish Society of Oncology 2025-12-01
Edice:	Journal of Oncological Sciences
Témata:	immunotherapy nivolumab non-small cell lung cancer renal cell carcinoma sodium prognosis
On-line přístup:	https://journalofoncology.org/articles/the-impact-of-sodium-on-prognosis-in-rcc-and-nsclc-patients-receiving-second-line-nivolumab-treatment/doi/jos.galenos.2025.2025-8-12
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!